User login
Patients who recently experienced an MI and had an ejection fraction of 35% or less who used a wearable cardioverter-defibrillator had no decreased risk of arrhythmic death, compared with people who did not use a wearable cardioverter-defibrillator, according to an analysis of data from the multicenter, randomized, and controlled VEST trial (NCT01446965). The results were published Sept. 26 in the New England Journal of Medicine (doi: 10.1056/NEJMoa1800781).
We covered this story before it was published in the journal. Find our conference coverage at the links below.
Patients who recently experienced an MI and had an ejection fraction of 35% or less who used a wearable cardioverter-defibrillator had no decreased risk of arrhythmic death, compared with people who did not use a wearable cardioverter-defibrillator, according to an analysis of data from the multicenter, randomized, and controlled VEST trial (NCT01446965). The results were published Sept. 26 in the New England Journal of Medicine (doi: 10.1056/NEJMoa1800781).
We covered this story before it was published in the journal. Find our conference coverage at the links below.
Patients who recently experienced an MI and had an ejection fraction of 35% or less who used a wearable cardioverter-defibrillator had no decreased risk of arrhythmic death, compared with people who did not use a wearable cardioverter-defibrillator, according to an analysis of data from the multicenter, randomized, and controlled VEST trial (NCT01446965). The results were published Sept. 26 in the New England Journal of Medicine (doi: 10.1056/NEJMoa1800781).
We covered this story before it was published in the journal. Find our conference coverage at the links below.
FROM NEW ENGLAND JOURNAL OF MEDICINE